Showing results (3841-3850 of 6,740) with videos related to

Sort By:
Pageof 674
Oncotargets and Therapy|December 7, 2018
Clinicopathological and prognostic significance of circulating tumor cells in patients with esophageal cancer: a meta-analysisJinxuan Hou, Kun Zou, Chaogang Yang, et al.
Oncotargets and Therapy|December 7, 2018
Celecoxib suppresses cutaneous squamous-cell carcinoma cell migration via inhibition of SDF1-induced endocytosis of CXCR4Ting Gong, Yan Yu, Bo Yang, et al.
Oncotargets and Therapy|December 7, 2018
Expression of CLIC1 as a potential biomarker for oral squamous cell carcinoma: a preliminary studyYing Xu, Jie Xu, Jiali Feng, et al.
Oncotargets and Therapy|December 21, 2018
Prognostic roles of mRNA expression of peroxiredoxins in lung cancerLiangyuan Chen, Chunli Huang, Xiaojun Yang, et al.
Oncotargets and Therapy|December 22, 2018
Drug-target-disease network analysis of gene-phenotype connectivity for genistein in ovarian cancerChen Zhang, Fan Yang, Suiqin Ni, et al.
Oncotargets and Therapy|December 22, 2018
Good local tumor control but lethal hemorrhage after apatinib treatment for intractable squamous carcinoma of the floor of the mouth: a case reportXiaopeng Zhu, Min Liu, Jincai Lv, et al.
Oncotargets and Therapy|December 22, 2018
Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanismsEthan B Ludmir, Tyler Gutschenritter, Chelsea C Pinnix, et al.
Oncotargets and Therapy|December 26, 2018
Elevated FAM3C promotes cell epithelial- mesenchymal transition and cell migration in gastric cancerMengyue Shi, Guihua Duan, Shuang Nie, et al.
Oncotargets and Therapy|December 26, 2018
Local analgesic effect of a bioadhesive barrier-forming oral liquid in cancer patients with oral mucositis caused by chemotherapy and/or radiotherapy: a randomized multicenter, single-use, positive-controlled, open-label studyYuan Cheng, Shu Kui Qin, Yan Ping Chen, et al.
Oncotargets and Therapy|December 26, 2018
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trialYi-Long Wu, Chong-Rui Xu, Cheng-Ping Hu, et al.
Pageof 674